Rhenovia Pharma Recognized as the World Leader in Biosimulation of the Central Nervous System
2/4/2013 2:40:11 PM
More...
|
Rhenovia Files Two Patent Applications for RHEpatch™, an Electronic Transdermal Patch for Controlled Drug Delivery
11/28/2012 1:31:31 PM
More...
|
Rhenovia Files Patents for New Treatment of Huntington's Disease Based on Its Innovative Biosimulation Platform
5/31/2012 9:13:43 AM
More...
|
Rhenovia Launches Drug Discovery Programs in Rare, Orphan and Neglected Neurodegenerative Diseases
3/19/2012 9:36:15 AM
More...
|
Rhenovia Opens First US Office
1/25/2012 9:13:45 AM
More...
|
Rhenovia's RHETOX Project is Selected by France's Ministries of Defense and Economy, for Financing of EUR 1.15 Million
9/1/2011 10:17:29 AM
More...
|
Rhenovia Enters Into a Strategic Alliance with Portmann Instruments for Marketing its Biosimulation Services in Switzerland
5/25/2011 1:36:23 PM
More...
|
Rhenovia Signs an R&D Contract with Sodiaal-Candia for Studying the Nutritional and Therapeutic Value of Milk and its Derivatives
4/26/2011 11:07:01 AM
More...
|
Rhenovia Signs Two-Year EUR 500,000 Partnership With AFM to Support its Simulation Technology for Diseases of the Nervous System
12/9/2010 11:21:22 AM
More...
|
Rhenovia Obtains Significant Research Contract With The US National Institutes of Health (NIH)
7/29/2009 12:28:49 PM
More...
|